Replies to post #13046 on Amarin Corp Plc (AMRN)

[wmjenkins3938]

New scripts increasing 14% monthly, refills increasing 10%!

[bravo33]

Lovaza is falling flat on its face, Niaspan is racing it to the bottom. GSK is crying for help and their is only one place to go. Everyone in BP knows it and is waiting past AdCom for first move to be made. In meantime scripts growth is steady while Anchor is coming right along. Much good my friend.